Contrast-induced nephropathy: pharmacological prophylaxis.
暂无分享,去创建一个
[1] Y. Li,et al. [Nephrotoxicity of high- and low-osmolar contrast media: Protective role of fosinopril or telmisartan in a rat model]. , 2000, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[2] E. Kline-Rogers,et al. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. , 2005, The American journal of medicine.
[3] K. Shojania,et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. , 2004, The American journal of medicine.
[4] D. Greenwood,et al. Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention , 2004, Circulation.
[5] C. McCulloch,et al. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[6] P. McLaughlin,et al. N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up. , 2004, American heart journal.
[7] A. Levin,et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. , 2004, American heart journal.
[8] A. Colombo,et al. N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity , 2004 .
[9] M. Tonelli,et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. , 2004, Kidney international.
[10] C. Poole,et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.
[11] B. Krämer,et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. , 2004, Journal of the American Society of Nephrology : JASN.
[12] E. Schwammenthal,et al. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature. , 2004, European heart journal.
[13] A. Colombo,et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. , 2004, European heart journal.
[14] B. Altun,et al. Radiocontrast-induced nephrotoxicity and urinary alpha-glutathione S-transferase levels: Effect of amlodipine administration , 2004, International Urology and Nephrology.
[15] B. Jaber,et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] P. O'Malley,et al. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. , 2003, The American journal of cardiology.
[17] D. Hilleman,et al. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. , 2003, American heart journal.
[18] J. Morrow,et al. The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. , 2003, Kidney International.
[19] G. Stone,et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. , 2003, JAMA.
[20] F. Markowetz,et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis , 2003, The Lancet.
[21] A. Wragg,et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. , 2003, Journal of the American College of Cardiology.
[22] M. Seyfarth,et al. Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. , 2003, The American journal of cardiology.
[23] S. Sdringola,et al. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] Chi‐Hang Lee,et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. , 2003, JAMA.
[25] S. Heyman,et al. N-acetylcysteine ameliorates renal microcirculation: studies in rats. , 2003, Kidney international.
[26] H. Miller,et al. Effects of an Acute Dose of L-Arginine during Coronary Angiography in Patients with Chronic Renal Failure , 2003, American Journal of Nephrology.
[27] S. Fishbane,et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. , 2002, Kidney international.
[28] S. Allaqaband,et al. Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathy , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[29] N. Sinha,et al. The role of theophylline in contrast-induced nephropathy: a case-control study. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] K. Shyu,et al. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. , 2002, Journal of the American College of Cardiology.
[31] D. Hunter,et al. Using a dopamine type 1A receptor agonist in high-risk patients to ameliorate contrast-associated nephropathy. , 2002, AJR. American journal of roentgenology.
[32] B. Villari,et al. Acetylcysteine and contrast agent-associated nephrotoxicity. , 2002, Journal of the American College of Cardiology.
[33] M. Classen,et al. Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study. , 2002, Radiology.
[34] J. Tumlin,et al. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. , 2002, American heart journal.
[35] Samin K. Sharma,et al. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam. , 2002, The American journal of cardiology.
[36] Douglas Losordo,et al. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.
[37] Chen Km,et al. Radiographic contrast media induced nephropathy: experimental observations and the protective effect of calcium channel blockers , 2001 .
[38] N. Shammas,et al. Aminophylline does not protect against radiocontrast nephropathy in patients undergoing percutaneous angiographic procedures. , 2001, The Journal of invasive cardiology.
[39] D. Weaver,et al. Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[40] H. Izzedine,et al. Effect of N-acetylcysteine on serum creatinine level. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[41] M. Classen,et al. Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk , 2001, Intensive Care Medicine.
[42] Y. Peng,et al. Nephrotoxicity of high- and low-osmolar contrast media: The protective role of amlodipine in a rat model , 2000, Acta radiologica.
[43] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[44] M. Rudnick,et al. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. , 2000, Kidney international.
[45] U. Mödder,et al. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] M. Gotsman,et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. , 1999, Journal of the American College of Cardiology.
[47] R. Luther,et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. , 1999, Critical care medicine.
[48] G. Bakris,et al. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors. , 1999, Kidney international.
[49] T. Risler,et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insu ffi ciency by hydration in combination with the adenosine antagonist theophylline , 1999 .
[50] M. Tariq,et al. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[51] W. O’Neill,et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .
[52] M. Leon,et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. , 1999, The American journal of cardiology.
[53] A. Więcek,et al. The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents. , 1998, Journal of nephrology.
[54] C. Dmuchowski,et al. Effect of dopamine on renal function after arteriography in patients with pre-existing renal insufficiency. , 1998, The American surgeon.
[55] E. Bates,et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[56] N. Sinha,et al. Use of dopamine in prevention of contrast induced acute renal failure--a randomised study. , 1996, International journal of cardiology.
[57] M. Cova,et al. Dose effect of nitrendipine on urinary enzymes and microproteins following non-ionic radiocontrast administration. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[58] T. Skau,et al. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function? , 1996, Scandinavian journal of urology and nephrology.
[59] T. Wiegmann,et al. Effects of Misoprostol on Contrast-Induced Renal Dysfunction. , 1995, American journal of therapeutics.
[60] B. Memoli,et al. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. , 1995, Journal of the American Society of Nephrology : JASN.
[61] G. Taylor,et al. Nephrotoxicity from contrast media: attenuation with theophylline. , 1995, Radiology.
[62] A. P. Shapiro,et al. The Effect of Prophylactic Nifedipine on Renal Function in Patients Administered Contrast Media , 1995, Pharmacotherapy.
[63] J. D'Elia,et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.
[64] P. Huppert,et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. , 1994, Kidney international.
[65] P. Kurnik,et al. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. , 1993, Renal failure.
[66] V. Bernhard,et al. Contrast-induced nephrotoxicity: the effects of vasodilator therapy. , 1992, The Journal of surgical research.
[67] C. Romanowski,et al. The use of theophylline, an adenosine antagonist in the prevention of contrast media induced nephrotoxicity. , 1992, The British journal of radiology.
[68] K. Margulies,et al. Induction and prevention of radiocontrast-induced nephropathy in dogs with heart failure. , 1990, Kidney international.
[69] N. Patel,et al. Renal functional response to dopamine during and after arteriography in patients with chronic renal insufficiency. , 1990, Radiology.
[70] A. Testa,et al. Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. , 1990, Nephron.
[71] A. Wenning,et al. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomised clinical trial. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[72] P. Cacoub,et al. No evidence for protective effects of nifedipine against radiocontrast-induced acute renal failure. , 1988, Clinical nephrology.
[73] J. Pourrat,et al. Renal side effect of nifedipine , 1984, Clinical cardiology.